AL-LAD Blotters – 150mcg
€ 44,75 – € 560,00Price range: € 44,75 through € 560,00
AL-LAD Blotters 150mcg are described as blotter-paper research preparations associated with 6-allyl-6-nor-lysergic acid diethylamide, a synthetic lysergamide structurally related to LSD.
The named compound, also referred to as 6-allyl-6-nor-LSD or ALLY-LAD, is distinguished by its 6-allyl substitution pattern.
The supplied source identifies individual blotter squares with a labeled analyte quantity, intended for controlled analytical and non-clinical laboratory research.
Relevant scientific contexts include chemical identity assessment, chromatographic characterization, structural comparison, and investigation of related lysergamides.
The source reports CAS number 65527-61-9, molecular formula C22H27N3O, and molecular weight approximately 349–351 g/mol.
It also refers to HPLC, GC-MS, NMR, or LC-MS verification, batch identification, and Certificate of Analysis documentation.
However, no actual batch-specific analytical report or supporting certificate was supplied.
The ingredient purity, finished-unit analyte content, content uniformity, substrate composition, chemical form, and storage stability remain unverified.
The blotters are not established as certified reference materials or validated quantitative calibration standards.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
AL-LAD Blotters 150mcg – Allyl Lysergamide Research Material
AL-LAD Blotters 150mcg – Product Overview
AL-LAD Blotters 150mcg is the supplied catalog designation for a blotter-format research preparation associated with AL-LAD.
The named compound belongs to the lysergamide family and is structurally related to lysergic acid diethylamide.
Its molecular structure differs from LSD through a 6-allyl-6-nor substitution pattern.
The supplied source presents the product as individual blotter-paper squares intended for controlled analytical and non-clinical laboratory research.
Each finished blotter is described as having a labeled analyte quantity.
However, no actual finished-unit assay or content-uniformity report accompanied the information.
The labeled quantity therefore remains a source-provided specification rather than an independently verified analytical result.
The supplied scientific context includes chemical identification, chromatographic characterization, structural comparison, and stability-focused investigation.
These research contexts should be distinguished from verified findings about the actual finished blotters.
No batch-specific analytical identity certificate, impurity profile, or validated assay result was provided.
The source also refers to HPLC, GC-MS, NMR, or LC-MS verification, batch identification, and Certificate of Analysis documentation.
These statements remain unverified without supporting records.
The finished preparation is not established as a certified reference material, validated quantitative calibrator, or approved pharmaceutical product.
Chemical Identity & Classification
The supplied source identifies AL-LAD as 6-allyl-6-nor-lysergic acid diethylamide.
It is a synthetic lysergamide structurally related to LSD.
The 6-allyl substitution pattern distinguishes the named compound from LSD and other lysergamide derivatives.
The supplied chemical information includes:
- Common designation: AL-LAD
- Alternative names: 6-Allyl-6-nor-LSD, ALLY-LAD
- Descriptive chemical name: 6-Allyl-6-nor-lysergic acid diethylamide
- Reported CAS Registry Number: 65527-61-9
- Reported molecular formula: C22H27N3O
- Calculated molecular weight from reported formula: Approximately 349.48 g/mol
- Chemical classification: 6-substituted lysergamide
- Reported presentation: Blotter-paper squares
- Labeled analyte amount: Specified per finished blotter
- Intended designation: Research Use Only
The reported formula and calculated molecular weight are internally consistent.
However, their assignment to the actual product batch has not been independently verified.
The supplied source also does not provide a batch-specific salt-form determination or complete stereochemical characterization.
The molecular structure of the named compound does not establish the composition of the finished blotter preparation.
Additional substrate materials or formulation components may be present, but the source does not identify them.
Researchers may consult PubChem for public chemical-reference information, ensuring that any selected database entry corresponds to the actual molecular structure, stereochemistry, and chemical form being examined.
Chemical & Physical Characteristics
The supplied source describes the product as small blotter-paper squares with printed markings.
No actual product-specific physical inspection report, image verification, or batch appearance record was supplied.
A blotter is a finished preparation in which the named analyte is associated with a carrier substrate.
The characteristics of the complete preparation therefore differ from those of the isolated chemical compound.
The source does not identify the substrate composition, blotter dimensions, total unit mass, manufacturing method, or surface characteristics.
The named compound contains a 6-allyl substitution pattern within the lysergamide framework.
This structural feature distinguishes AL-LAD from LSD and from related derivatives containing different substituents.
The source also claims solubility in ethanol, methanol, acetonitrile, and DMSO.
However, no experimentally verified solubility measurements, substrate-extraction studies, or product-specific solvent compatibility records were supplied.
These statements should not be treated as validated extraction or analytical recovery characteristics of the finished blotters.
The source does not establish the distribution of analyte across the blotter substrate.
Consequently, the properties of the isolated compound should not be assumed to describe the complete finished unit.
Purity & Analytical Verification
The supplied source refers to a typical ingredient purity of approximately 98–99% where verified.
However, no actual batch-specific Certificate of Analysis or laboratory report accompanied that statement.
The reported purity range therefore remains a supplier-provided claim rather than an independently verified result.
The source refers to HPLC, GC-MS, NMR spectroscopy, and LC-MS as analytical verification methods.
No chromatogram, mass spectrum, NMR spectrum, impurity profile, or independent laboratory certificate was supplied.
Accordingly, no specific purity result can be confirmed for the actual product batch.
For AL-LAD Blotters 150mcg, the chemical purity of the named ingredient and the actual analyte quantity in each finished unit are separate analytical characteristics.
An ingredient-purity result does not independently establish finished-unit content or content uniformity.
The source also does not establish whether any claimed purity measurement applies to isolated bulk material or the complete finished preparation.
The material is described in reference-oriented research terms.
However, no certified reference-material documentation, assigned measurement value, uncertainty statement, or metrological traceability record was supplied.
The finished blotters should therefore not be represented as certified quantitative reference standards. AL-LAD Blotters 150mcg
Any definitive analytical claims require actual supporting batch records.
Quality Control & Batch Integrity
The supplied source refers to batch identification, analytical verification, and Certificate of Analysis documentation.
These statements describe proposed or claimed quality-assurance practices.
No actual certificate, independent testing report, manufacturing audit, or batch-specific quality-control record accompanied the information.
They therefore remain unverified supplier claims.
For reproducible analytical documentation, relevant records may include verified chemical identifiers, confirmed stereochemical composition where available, batch number, analytical findings, receipt date, and available storage history.
For AL-LAD Blotters 150mcg, the identity and purity of the named compound should be distinguished from the composition and consistency of the finished units.
The supplied information does not establish independently verified analyte content, substrate composition, or content uniformity.
The source also does not provide evidence that every finished blotter meets a particular quantitative specification.
The Research Use Only designation describes intended positioning but does not independently demonstrate manufacturing quality or analytical traceability. AL-LAD Blotters 150mcg
Claims concerning batch consistency and validated analytical performance should be supported by actual records.
Safety, Handling & Laboratory Precautions
AL-LAD is a synthetic lysergamide associated with significant pharmacological activity and potential toxicological uncertainty.
The supplied source does not provide a complete product-specific toxicological assessment.
Laboratory personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.
Relevant precautions include restricted access, appropriate protective equipment, contamination prevention, accidental-exposure procedures, and chemical-waste management.
The blotter presentation does not establish safety for human or veterinary exposure.
The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.
Because the actual chemical form, ingredient purity, substrate composition, and finished-unit content have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements. AL-LAD Blotters 150mcg
Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.
Packaging, Labeling & Storage
The supplied source describes discreet packaging, batch-aware handling, tracking, and protective shipment arrangements.
No actual packaging specification, container-validation report, or shipment-condition record was provided.
The source recommends storage in a sealed, moisture-resistant container in a cool, dry environment protected from light.
It also suggests refrigeration at approximately 2–8°C.
No validated product-specific stability study was supplied to establish that temperature range as a verified requirement or to support a particular shelf life. AL-LAD Blotters 150mcg
For AL-LAD Blotters 150mcg, laboratory inventory records should preserve the product designation, any available batch identifier, receipt details, and relevant storage observations.
The labeled analyte quantity should be recorded as a source-provided specification unless independently verified.
Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional procedures.
Intended Research Use & Market Positioning
The supplied scientific context places AL-LAD within analytical research involving lysergamide chemical identity, 6-position substitution, and comparative structural characterization.
The allyl substituent provides a distinguishing structural feature relevant to chemical analysis.
The source also describes interest in chromatographic profiling, forensic analytical characterization, and stability-focused laboratory research.
However, no product-specific analytical validation, receptor-binding dataset, or stability study was supplied for the actual blotters. AL-LAD Blotters 150mcg
The Raw Lab Chems catalog identifies AL-LAD Blotters as the product listing discussed here.
For related chemical-family context, the supplied catalog also includes 1B-LSD Blotters and LSZ Blotters.
These listings refer to distinct lysergamide compounds or preparations.
AL-LAD, 1B-LSD, and LSZ should not be treated as chemically identical or analytically interchangeable.
The supplied information does not establish equivalent chemical purity, analyte content, substrate composition, or content uniformity across these preparations.
These catalog references should not be interpreted as evidence of certified reference-material status or validated quantitative equivalence.
Ordering, Availability & Fulfillment
The supplied source describes protective packaging, international shipping, tracking, and secure handling arrangements.
It also identifies possible labeled pack sizes. AL-LAD Blotters 150mcg
No current inventory record, confirmed pack-size listing, carrier agreement, shipment authorization, or verified delivery information was supplied.
Consequently, no availability, pack-size, delivery-time, customs-clearance, or transportation-compliance guarantee is asserted.
AL-LAD may be subject to controlled-substance, analogue, pharmaceutical, or other chemical regulations depending on the jurisdiction.
Institutional acquisition, possession, transportation, importation, and exportation must be assessed under applicable laws.
Research-only labeling does not establish a legal exemption.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
AL-LAD is a synthetic lysergamide whose possession, acquisition, transfer, transportation, importation, exportation, and laboratory investigation may be restricted or prohibited depending on the jurisdiction.
The supplied information does not establish universal legal status or regulatory authorization.
Institutions remain responsible for determining applicable legal requirements and obtaining any necessary permissions.
No medical approval, consumer-use authorization, or regulatory exemption is implied by this description.
| Quantity (blotters) |
5 ,10 ,25 ,50 ,100 |
|---|
You must be logged in to post a review.

Reviews
There are no reviews yet.